Overview

Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of imatinib on dermatofibrosarcoma protuberan tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Sarcoma Alliance for Research through Collaboration
Treatments:
Imatinib Mesylate